Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis.
The effectiveness of percutaneous balloon compression in the treatment of trigeminal neuralgia in patients with multiple sclerosis.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity.
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study.
Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Venous endothelial injury in central nervous system diseases.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
Special considerations when coding for patients with multiple sclerosis.
Speed of word retrieval in multiple sclerosis.
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
Gene set differential analysis of time course expression profiles via sparse estimation in functional logistic model with application to time-dependent biomarker detection.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Pages
« first
‹ previous
…
487
488
489
490
491
492
493
494
495
…
next ›
last »